Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Terns Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 65
- +20 vs. Q3 2022
- Shares held
- 49.7M
- +19.4M (+64.2%) vs. Q3 2022
- Total value
- $506.2M
- +$328.1M (+184.2%) vs. Q3 2022
- New holders
- 25
- 23 more added
- Sold out
- 5
- 14 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 126 | $1.28K | 0.00% | +4+3.3% | Added |
| Capital Advisors, Ltd. LLC | 188 | $2.00K | 0.00% | −12−6.0% | Reduced |
| Royal Bank of Canada | 182 | $2.00K | 0.00% | +182 | New |
| Daiwa Securities Group Inc. | 151 | $2.00K | 0.00% | +151 | New |
| China Universal Asset Management Co., Ltd. | 383 | $3.90K | 0.00% | +30+8.5% | Added |
| Bank of America Corp | 1,815 | $18.5K | 0.00% | −5,911−76.5% | Reduced |
| Cubist Systematic Strategies, LLC | 4,865 | $49.5K | 0.00% | +4,865 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,050 | $51.4K | 0.00% | +5,050 | New |
| Tower Research Capital LLC (TRC) | 5,539 | $57.0K | 0.00% | −1,062−16.1% | Reduced |
| Qube Research & Technologies Ltd | 10,545 | $107.3K | 0.00% | −264−2.4% | Reduced |
| Velan Capital Investment Management LP | 10,646 | $108.4K | 0.12% | +10,646 | New |
| Goldman Sachs Group Inc | 10,830 | $110.2K | 0.00% | −1,086−9.1% | Reduced |
| Raymond James & Associates | 12,488 | $127.1K | 0.00% | +12,488 | New |
| Man Group plc | 13,763 | $140.1K | 0.00% | +13,763 | New |
| Crosspoint Financial, LLC | 15,054 | $153.3K | 1.69% | +15,054 | New |
| Dynamic Technology Lab Private Ltd | 15,709 | $160.0K | 0.02% | +15,709 | New |
| Morgan Stanley | 18,058 | $183.8K | 0.00% | +10,815+149.3% | Added |
| Caas Capital Management LP | 20,000 | $203.6K | 0.04% | −65,851−76.7% | Reduced |
| Jane Street Group, LLC | 21,507 | $218.9K | 0.00% | +8,252+62.3% | Added |
| Acadian Asset Management LLC | 22,599 | $229.0K | 0.00% | +9,972+79.0% | Added |
| Alps Advisors Inc | 25,525 | $259.8K | 0.00% | +25,525 | New |
| 683 Capital Management, LLC | 28,000 | $285.0K | 0.03% | +28,000 | New |
| Northern Trust Corp | 31,593 | $321.6K | 0.00% | +10,089+46.9% | Added |
| HRT Financial LP | 35,090 | $357.0K | 0.01% | +35,090 | New |
| Marshall Wace, LLP | 36,081 | $367.3K | 0.00% | +36,081 | New |
| Susquehanna International Group, LLP | 38,102 | $387.9K | 0.00% | +38,102 | New |
| Citigroup Inc | 46,048 | $468.8K | 0.00% | +45,347+6,468.9% | Added |
| State Street Corp | 59,537 | $606.1K | 0.00% | +17,500+41.6% | Added |
| Altium Capital Management LP | 70,000 | $712.6K | 0.36% | +70,000 | New |
| Walleye Capital LLC | 73,611 | $749.4K | 0.02% | +61,487+507.2% | Added |
| HighVista Strategies LLC | 77,344 | $787.4K | 0.47% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 92,700 | $943.7K | 0.02% | +23,200+33.4% | Added |
| Dimensional Fund Advisors LP | 98,940 | $1.01M | 0.00% | +65,628+197.0% | Added |
| Polar Asset Management Partners Inc. | 100,000 | $1.02M | 0.01% | +100,000 | New |
| Renaissance Technologies LLC | 114,900 | $1.17M | 0.00% | −37,300−24.5% | Reduced |
| Monashee Investment Management LLC | 122,500 | $1.25M | 0.54% | +122,500 | New |
| Boothbay Fund Management, LLC | 125,882 | $1.28M | 0.04% | −9,837−7.2% | Reduced |
| EAM Investors, LLC | 128,186 | $1.30M | 0.27% | +128,186 | New |
| Endurant Capital Management LP | 135,994 | $1.38M | 0.56% | +135,994 | New |
| Geode Capital Management, LLC | 177,648 | $1.81M | 0.00% | +8,800+5.2% | Added |
| Bank of Montreal | 194,100 | $1.98M | 0.00% | +194,100 | New |
| Samsara BioCapital, LLC | 202,348 | $2.06M | 0.44% | −86,720−30.0% | Reduced |
| Point72 Asset Management, L.P. | 233,500 | $2.38M | 0.01% | +233,500 | New |
| BlackRock Inc. | 299,438 | $3.05M | 0.00% | +13,145+4.6% | Added |
| Citadel Advisors LLC | 515,797 | $5.25M | 0.01% | +515,797 | New |
| Barclays PLC | 516,739 | $5.26M | 0.00% | −142,359−21.6% | Reduced |
| Armistice Capital, LLC | 560,000 | $5.70M | 0.15% | −40,000−6.7% | Reduced |
| Pura Vida Investments, LLC | 605,079 | $6.16M | 1.03% | −123,521−17.0% | Reduced |
| Silverarc Capital Management, LLC | 700,000 | $7.13M | 2.45% | +685,527+4,736.6% | Added |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $7.27M | 2.72% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 737,319 | $7.51M | 3.11% | −166,800−18.4% | Reduced |
| Franklin Resources Inc | 750,024 | $7.64M | 0.00% | +750,024 | New |
| RTW Investments, LP | 1,000,000 | $10.2M | 0.21% | +1,000,000 | New |
| Acuta Capital Partners, LLC | 1,100,000 | $11.2M | 6.89% | +749,298+213.7% | Added |
| Vanguard Group Inc | 1,126,036 | $11.5M | 0.00% | +506,904+81.9% | Added |
| JPMorgan Chase & Co | 1,207,151 | $12.3M | 0.00% | +288,109+31.3% | Added |
| Millennium Management LLC | 1,457,205 | $14.8M | 0.02% | +1,074,492+280.8% | Added |
| Fairmount Funds Management LLC | 2,040,000 | $20.8M | 3.29% | −10,000−0.5% | Reduced |
| Driehaus Capital Management LLC | 2,294,376 | $23.4M | 0.35% | +696,447+43.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,851,287 | $29.0M | 0.60% | +991,287+53.3% | Added |
| Suvretta Capital Management, LLC | 3,448,275 | $35.1M | 1.47% | +3,448,275 | New |
| VR Adviser, LLC | 3,707,891 | $37.7M | 6.36% | 00.0% | Unchanged |
| Vivo Capital, LLC | 6,657,992 | $67.8M | 8.21% | +758,620+12.9% | Added |
| FMR LLC | 7,378,641 | $75.1M | 0.01% | +7,277,002+7,159.7% | Added |
| OrbiMed Advisors LLC | 7,619,135 | $77.6M | 1.49% | +137,931+1.8% | Added |
| Commodore Capital LP | 0 | $0 | 0.00% | −205,870−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −20,830−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,408−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,945−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,667−100.0% | Sold out |